ROYAL BANK OF CANADA - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q1 2018$8,000
-11.1%
42,050
-1.4%
0.00%
Q4 2017$9,000
+200.0%
42,630
+277.3%
0.00%
Q3 2017$3,000
-50.0%
11,300
-2.8%
0.00%
Q2 2017$6,000
-68.4%
11,626
+87.5%
0.00%
Q1 2017$19,000
+35.7%
6,2000.0%0.00%
Q4 2016$14,000
+16.7%
6,200
+47.6%
0.00%
Q3 2016$12,0000.0%4,2000.0%0.00%
Q2 2016$12,000
-14.3%
4,2000.0%0.00%
Q1 2016$14,000
-78.5%
4,200
-72.5%
0.00%
Q4 2015$65,000
+6400.0%
15,260
+7530.0%
0.00%
Q3 2015$1,0002000.00%
Other shareholders
ESSA PHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,090,909$6,884,0003.88%
DAFNA Capital Management LLC 228,500$1,424,0001.41%
ACUTA CAPITAL PARTNERS, LLC 288,400$1,797,0001.04%
AWM Investment Company, Inc. 727,272$4,552,0000.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,859,282$11,580,0000.45%
ACADIAN ASSET MANAGEMENT LLC 17,900$113,0000.00%
MORGAN STANLEY 12,500$72,0000.00%
BANK OF MONTREAL /CAN/ 1,000$8,0000.00%
Tower Research Capital LLC (TRC) 800$5,0000.00%
ROYAL BANK OF CANADA 200$1,0000.00%
View complete list of ESSA PHARMA INC shareholders